Soprobec® is a registered trademark of Glenmark Pharmaceuticals Europe Limited.
Clenil® Modulite® are registered trademarks of Chiesi Limited.
VolumaticTM is a trademark of the GlaxoSmithKline group of companies.
PIP codes: Soprobec 50 mcg/actuation - 4098620,
Soprobec 100 mcg/actuation- 4098638,
Soprobec 200 mcg/actuation - 4098646,
Soprobec 250 mcg/actuation - 4098653.
© 2024 Glenmark Pharmaceuticals Europe Ltd. All rights reserved. Date of preparation: July 2021 PP-UK-SOP-0139
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’
By clicking this link, you are leaving the Soprobec website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’